Lichen Sclerosus: Clinical Trials

2 trials for Lichen Sclerosus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Recruiting 1

Follow Lichen Sclerosus: new trials by email Literature Review of Lichen Sclerosus trials Research Report on Lichen Sclerosus

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus
Delgocitinib, Cream Vehicle - Lichen Sclerosus
Phase 3RecruitingLEO Pharma6522026-05-012026-10-13
Laser vs Clobetasol for Lichen Sclerosus
Clobetasol 0.05% Emollient Top Cream, Non-ablative CO2 Laser - Lichen Sclerosus
Phase 3CompletedRuhr University of Bochum2462021-11-022025-12-04

Narrower conditions

Lichen Sclerosus et Atrophicus (2)

Broader conditions

Lichenoid Eruptions (2)  ·  Skin Diseases (2)  ·  Skin Diseases, Papulosquamous (2)  ·  Skin and Connective Tissue Diseases (2)

Interventions

Clobetasol (1)  ·  delgocitinib (1)

Sponsors

LEO Pharma (1)  ·  Ruhr University of Bochum (1)

Countries

Canada (1)  ·  Germany (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Clemens B Tempfer, MD (1)

Results publications

PMID 42208069

NIH funding

2025 (1)